13 April 2021>: Articles
Spontaneous Bacterial Peritonitis in an Adult Patient with Minimal Change Disease
Rare disease
In Hee Lee A* , Hong Ik Kim B , Min-Kyung Kim B , Dong Jik Ahn CDOI: 10.12659/AJCR.930677
Am J Case Rep 2021; 22:e930677
Table 1. Cases of spontaneous bacterial peritonitis in adult patients with nephrotic syndrome.
Year reported | Age (years)/Gender | Renal pathology | Duration* (months) | Causative microoragnism | Immuno-suppressants | BUN/Cr (mg/dL) | SA (g/dL) | Antibiotic therapy | Clinical outcome |
---|---|---|---|---|---|---|---|---|---|
1978 []4 | 41/F | FSGS | 2 years | None | NR | 1.2 | Ampicillin | Cure | |
1993 []5 | 25/M | FSGS | 15 years | None | 53.5/6.0 | 1.8 | IMP/TM | Cure | |
1999 []6 | 28/F | MPGN | 0 | None | 28/3.1 | 2.2 | CP/Oxacillin | Cure | |
1999 []7 | 20/M | MCD | 2 years | PDL | 51/3.2 | 1.3 | NR | Cure | |
1999 []7 | 32/M | MCD | 1 year | No growth | PDL | 24/1.8 | 1.4 | NR | Cure |
1999 []7 | 48/M | No biopsy | 3 | PDL | 16/1.2 | 1.4 | NR | Cure | |
1999 []7 | 56/M | No biopsy | 0 | Acinetobacter | None | 10/0.7 | 1.2 | NR | Cure |
1999 []7 | 45/F | MCD | 0 | None | 39/1.4 | 0.7 | NR | Cure | |
1999 []7 | 49/M | No biopsy | 0 | PDL | 91/2.5 | 1.6 | NR | Death | |
1999 []7 | 25/M | MCD | 5 | CYP+CYS | 28/1.5 | 2.3 | NR | Death | |
1999 []7 | 29/M | No biopsy | 0 | No growth | None | 183/7.4 | 1.9 | NR | Death |
2005 []8 | 38/F | AA amyloidosis | 1 year | No growth | None | 47.3/5.6 | 1.3 | Cefotaxime | Cure |
2005 []8 | 30/F | AA amyloidosis | 8 | No growth | Methyl-PDL | 82.9/5.7 | 1.4 | Cefotaxime | Cure |
2018 []9 | 46/M | MCD | NR | None | 56.3/4.6 | PC/Cloxacillin | Cure | ||
Our case | 60/M | MCD | 6 | PDL+CYS | 104/3.2 | 1.7 | Cefotaxime/PT | Cure | |
* Duration of nephrotic syndrome prior to occurrence of spontaneous bacterial peritonitis. BUN – blood urea nitrogen; Cr – serum creatinine; SA – serum albumin; F – Female; M – Male; FSGS – focal segmental glomerulosclerosis; MPGN – membranoproliferative glomerulonephritis; MCD – minimal change disease; NR – not reported; ; CYP – cyclophosphamide; CYS – cyclosporine; PDL – prednisolone; IMP – imipenem; TM – tobramycin; CP – cephazolin; PC – penicillin-G; PT – piperacillin-tazobactam. |